The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120, which was initiated by Bernstein analyst Ronny Gal. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The number of analysts covering the stock of ABBV is greater than 92.45% of all US stocks. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. Start My Free Trial No credit card required. AbbVie (NYSE:ABBV) had its price target cut by SVB Leerink from $122.00 to $119.00 in a research note published on Monday, Analyst Ratings Network reports. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. in Medical - Pharmaceuticals. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. Several other research firms have also commented on ABBV. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. Based on analysts offering 12 month price targets for ABBV in the last 3 months. These are the details. The average price target is $119.50 with a high forecast of $128.00 and a low forecast of $110.00. During the day the stock fluctuated 1.44% from a day low at $104.30 to a day high of $105.80. Last 30 Days. Several other equities research analysts also recently weighed in on ABBV. In addition to the average rating from Wall Street analysts, ABBV stock has a mean target price of 110.812. In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $90.88, changing hands for $92.29/share. The average price target represents a 13.52% increase from the last price of $105.27. See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Now its price is around $91. This is 0.66% more than the trading day before Wednesday, 25th Nov 2020. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.43%. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The Fly. • 2 5G Stocks to Buy in January, 2 to Avoid, • Himax Technologies: A Top Tech Stock to Buy and Hold in 2021, • Avoid These 3 Tech Stocks in January: Zoom Video, SolarWinds, and Sabre, • 2 Buy-Rated Electric Vehicle Stocks to Grab in January: Nio and Blink Charging. To see all exchange delays and terms of use, please see disclaimer. ABBV's rank also includes a fundamental score of 74. The average price target represents a 10.00% increase from the last price of $109.49. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target Get daily stock ideas top-performing Wall Street analysts. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. View which stocks are hot on social media with MarketBeat's trending stocks report. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Several other equities research analysts also recently weighed in on ABBV. Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. 8/20/20 – Morgan Stanley increased its price target from $95 to $108 and rated the stock as overweight 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. See the POWR Ratings now! ▲ +8.48% Upside Potential This price target is based on 21 analysts offering 12 month … Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Dec. 22, 2020 at 5:45 p.m. Identify stocks that meet your criteria using seven unique stock screeners. They issued a “buy” rating and a $110.00 target price for the company. ABBV stock fell 3.7% that day. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). ET on Zacks.com 3 Stocks with Strong Dividends to Buy for Growth in 2021 AbbVie (NYSE:ABBV) had its price target raised by Mizuho from $111.00 to $117.00 in a research report released on Tuesday, The Fly reports. ABBV | Complete AbbVie Inc. stock news by MarketWatch. Most Recent Rating . By Daniel Collins 2 years ago. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.88 EPS, FY2020 earnings at $10.47 EPS, Q1 2021 earnings […] Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. On average, analysts give ABBV a Strong Buy rating. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Get the latest Zacks research report on ABBV …  Industry Rank, Ranked of 261 AbbVie (NYSE:ABBV) had its price target raised by SVB Leerink from $119.00 to $128.00 in a report issued on Wednesday, Analyst Ratings Network reports. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-30, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. The short-term technical score for ABBV is 64. The committee is investigating drug prices. (13.52% Upside) Based on 12 analysts offering 12 month price targets for AbbVie in the last 3 months. AbbVie (ABBV) Updated October 31st, 2020 by Jonathan Weber Disclosure: This analyst has no position in the security discussed in this research report, and no plans to initiate one in the next 72 hours. 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. Already a subscriber? Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Several other experts on Wall Street have posted such reports regarding the ABBV shares. Learn everything you need to know about successful options trading with this three-part video course. The chart below shows how a company's share price and consensus price target have changed over time. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. 21 brokers have issued 12-month price objectives for AbbVie's shares. ABBV updated stock price target summary. See what's happening in the market right now with MarketBeat's real-time news feed. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy.". When a stock reaches the target … The predicted price for ABBV in the upcoming period, according to Bernstein is $120 based on the research report published on November 10th of the current year 2020. AbbVie Inc. (NYSE:ABBV)’s beta value is holding at 0.76, while the average true range (ATR) indicator is presently reading 2.5. AbbVie shares recently traded at $85.44, up 1.76%. The dark blue line represents the company's actual price. Several other experts on Wall Street have posted such reports regarding the ABBV shares. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Copyright © 2021. Do Not Sell My Information. AbbVie Inc (NYSE: ABBV) dropped Friday after falling short of fourth-quarter earnings estimates.A $1.90 bottom line missed a $1.93 estimate, and sales of … The lighter blue line represents the stock's consensus price target. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120. Morgan Stanley currently has an overweight rating on the stock. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. Over the last 30 days, this security got 4 buy, 0 sell and 0 hold ratings. The average price target is $102.916, which means analysts expect the stock to climb by 4.00% over the next twelve months. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Fundamental company data provided by Morningstar and Zacks Investment Research. The firm currently has an outperform rating on the stock. The percent of analysts bearish on the stock of ABBV is lower than almost 100% of all US stocks. On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. ABBV has been the topic of several other research reports. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. ABBV Price Forecast Based on DCF Valuation. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis.  Buy & Hold Grade Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.85 EPS, FY2020 earnings at $10.43 EPS, Q1 2021 earnings […] Morgan Stanley raised their price target on shares of AbbVie from $108.00 to $120.00 and gave the company an overweight rating in a […] 2020: ABBVIE: UBS Adjusts AbbVie's Price Target to $124 From $118, Reiterates Buy Rat.. MT. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). That was well above Wall Street expectations. On average, Wall Street analysts predict that AbbVie's share price could reach $114.38 by Dec 22, 2021. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Looking for new stock ideas? Considering analysts have assigned the stock a price target range of $97-$127 as the low and high respectively, we find the trailing 12-month average consensus price target to be $111.45. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. With a 5-year investment, the revenue is expected to be around +54.14%. Start your free 7-Day Trial. The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity. Learn more. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations.